| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,461 | 23,644 | 28,166 | 47,293 | | Cost of Revenue | 26,322 | 10,673 | 11,244 | 23,564 | | | Gross Profit | 30,139 | 12,971 | 16,922 | 23,729 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,677 | 16,207 | 13,551 | 30,458 | | Non Recurring | 6,764 |
-
|
-
|
-
| | Others | 812 | 687 | 622 | 628 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,886 | (3,923) | 2,749 | (7,357) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| 10 | 58 | | Earnings Before Interest And Taxes | 4,886 | (3,923) | 2,759 | (7,299) | | Interest Expense | 97 | 56 | 15 | 17 | | Income Before Tax | 4,789 | (3,979) | 2,744 | (7,316) | | Income Tax Expense | 1,820 | (1,512) | 1,253 | (2,780) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,969 | (2,467) | 1,491 | (4,536) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,969 | (2,467) | 1,491 | (4,536) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,969 | ($2,467) | $1,491 | ($4,536) |
|
0.03% Nasdaq 
0.06 (2.71%) 
Income Statement
